Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses

Area of Science:

• Biochemistry
• Genetics
• Pharmacogenomics

Background:

• Apolipoprotein E (apo E) is a crucial protein for cholesterol transport and various physiological functions.
• Genetic variations, including common coding and promoter polymorphisms, influence apo E's role in lipid metabolism, cardiovascular health, neurodegenerative diseases, and longevity.

Purpose of the Study:

• To explore the clinical significance of apolipoprotein E (apo E) genetic polymorphisms and circulating apo E concentration.
• To evaluate the potential of apo E genotyping and concentration measurement for personalized medicine, including risk assessment and therapeutic response prediction.

Main Methods:

• Review of existing literature on apo E polymorphisms and their functional consequences.
• Analysis of the impact of apo E variants on lipid metabolism, disease susceptibility, and drug responses.
• Investigation into the role of circulating apo E concentration in health and disease states.

Main Results:

• Apo E coding polymorphism significantly affects lipid metabolism, disease risk (cardiovascular, neurodegenerative), and longevity.
• Apo E genotype influences patient responses to various drugs (statins, fibrates, etc.) and environmental factors (diet, alcohol).
• Circulating apo E concentration is altered in disease and can be modulated by certain medications, suggesting its potential as a clinical marker and therapeutic target.

Conclusions:

• Apo E genotyping can aid in defining patient risk and predicting therapeutic outcomes.
• Circulating apo E concentration offers valuable clinical information and may serve as a therapeutic target.
• Apo E concentration might be a more significant parameter than apo E polymorphisms in health and disease contexts.